Who owns the GVOKE VIALDX trademark?

The GVOKE VIALDX trademark is owned by Xeris Pharmaceuticals, Inc..

What class is the GVOKE VIALDX trademark registered in?

The GVOKE VIALDX trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations).

What is the serial number for GVOKE VIALDX?

The USPTO serial number for GVOKE VIALDX is 98978730.

What is the registration number for GVOKE VIALDX?

GVOKE VIALDX is registered under USPTO registration number 8414990.

GVO

USPTO Trademark Record

REGISTERED

GVOKE VIALDX

SN 98978730·Reg 8414990·Filed Sep 01, 2023

Owner Xeris Pharmaceuticals, Inc.

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

GVOKE VIALDX (Serial No. 98978730), Registration No. 8414990, is a registered US trademark filed on Sep 01, 2023 by Xeris Pharmaceuticals, Inc.. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations).

early section 8: August 25, 2032

Mark Intelligence

GVOKE VIALDX (Reg. #8414990) is a registered US trademark that has been protecting its owner, Xeris Pharmaceuticals, Inc., since 2023. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations). Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 1 opposition proceeding during prosecution.

FILED

Sep 01, 2023

SERIAL

98978730

REG#

8414990

REGISTERED

Aug 25, 2026

Owner

Applicant

Xeris Pharmaceuticals, Inc.

Entity

Corporation

State

Address

Suite 1300, 1375 West Fulton Street, Chicago, IL, 60607

Country

Attorney

NameTracy-Gene G. Durkin

Law firm

Tracy-Gene G. Durkin STERNE, KESSLER, GOLDSTEIN & FOX P.L.L.C.

Docket

4605.0980000

Address

1101 K STREET, NW, 10TH FLOOR, WASHINGTON, DC 20005, United States

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusREGISTERED

Filing DateSep 01, 2023

Serial Number98978730

Registration No.8414990

Registration DateAug 25, 2026

Status DateAug 25, 2026

Published for OppositionJun 11, 2024

Mark TypeStandard characters

Attorney Docket4605.0980000

Status DescriptionLive and registered

Filing Signals

FILED

2023

YEARS AGO

CLASSES

MADRID FILINGS

Opposed 1× during prosecution

Search 14M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 005, 006, 018, 044, 046, 051, 052

First use anywhere: Aug 19, 2025

First use in commerce: Aug 19, 2025

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

32 events

REGISTERED-PRINCIPAL REGISTER

Aug 25, 2026

REGISTERED-PRINCIPAL REGISTER

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Aug 25, 2026

NOTICE OF REGISTRATION CONFIRMATION EMAILED

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Aug 05, 2026

CASE ASSIGNED TO INTENT TO USE PARALEGAL

DIVISIONAL PROCESSING COMPLETE

Aug 05, 2026

DIVISIONAL PROCESSING COMPLETE

STATEMENT OF USE PROCESSING COMPLETE

Aug 05, 2026

STATEMENT OF USE PROCESSING COMPLETE

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Aug 05, 2026

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Aug 05, 2026

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

CASE ASSIGNED TO INTENT TO USE PARALEGAL

May 20, 2026

CASE ASSIGNED TO INTENT TO USE PARALEGAL

USE AMENDMENT FILED

Jan 14, 2026

USE AMENDMENT FILED

TEAS STATEMENT OF USE RECEIVED

Jan 14, 2026

TEAS STATEMENT OF USE RECEIVED

DIVISIONAL REQUEST RECEIVED

Jan 14, 2026

DIVISIONAL REQUEST RECEIVED

TEAS REQUEST TO DIVIDE RECEIVED

Jan 14, 2026

TEAS REQUEST TO DIVIDE RECEIVED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Aug 06, 2025

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU TEAS EXTENSION RECEIVED

Aug 05, 2025

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 2 FILED

Aug 05, 2025

SOU EXTENSION 2 FILED

SOU EXTENSION 2 GRANTED

Aug 05, 2025

SOU EXTENSION 2 GRANTED

SOU TEAS EXTENSION RECEIVED

Feb 03, 2025

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 1 FILED

Feb 03, 2025

SOU EXTENSION 1 FILED

SOU EXTENSION 1 GRANTED

Feb 03, 2025

SOU EXTENSION 1 GRANTED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Feb 03, 2025

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Aug 06, 2024

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

PUBLISHED FOR OPPOSITION

Jun 11, 2024

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Jun 11, 2024

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

May 22, 2024

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

EXAMINERS AMENDMENT -WRITTEN

May 03, 2024

EXAMINERS AMENDMENT -WRITTEN

EXAMINERS AMENDMENT E-MAILED

May 03, 2024

EXAMINERS AMENDMENT E-MAILED

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

May 03, 2024

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

EXAMINER'S AMENDMENT ENTERED

May 03, 2024

EXAMINER'S AMENDMENT ENTERED

APPROVED FOR PUB - PRINCIPAL REGISTER

May 03, 2024

APPROVED FOR PUB - PRINCIPAL REGISTER

ASSIGNED TO EXAMINER

Apr 30, 2024

ASSIGNED TO EXAMINER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Sep 27, 2023

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Sep 05, 2023

NEW APPLICATION ENTERED

GVOKE VIALDX

Get pre-filing clearance

Search 14M+ trademarks

Run a conflict check

Other Marks by Xeris Pharmaceuticals, Inc.

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Other Marks by Tracy-Gene G. Durkin

Resources

Company